Claus Cursiefen Selected Research

Neoplasms (Cancer)

12/2023	Combined Osteopontin Blockade and Type 2 Classical Dendritic Cell Vaccination as Effective Synergetic Therapy for Conjunctival Melanoma.
1/2022	New Therapeutic Approaches for Conjunctival Melanoma-What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells.
9/2015	A Novel Model of Metastatic Conjunctival Melanoma in Immune-Competent Mice.
2/2015	Antilymphangiogenic therapy to promote transplant survival and to reduce cancer metastasis: what can we learn from the eye?
4/2014	Autocrine impact of VEGF-A on uveal melanoma cells.
5/2013	Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases.
2/2013	Evidence for the interaction of fibroblast growth factor-2 with the lymphatic endothelial cell marker LYVE-1.
1/2011	Intravital two-photon microscopy of immune cell dynamics in corneal lymphatic vessels.
8/2010	Intraocular lymphatics in ciliary body melanomas with extraocular extension: functional for lymphatic spread?
7/2010	Genetic heterogeneity of lymphangiogenesis in different mouse strains.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claus Cursiefen Research Topics

Disease

41	Corneal Neovascularization 12/2022 - 10/2002
18	Cataract (Cataracts) 04/2024 - 07/2012
17	Glaucoma 04/2024 - 08/2013
17	Inflammation (Inflammations) 05/2023 - 04/2004
17	Fuchs' Endothelial Dystrophy 03/2023 - 12/2007
15	Neoplasms (Cancer) 12/2023 - 04/2004
11	Keratoconus 01/2023 - 02/2006
11	Neoplasm Metastasis (Metastasis) 09/2015 - 04/2004
8	Wounds and Injuries (Trauma) 04/2024 - 07/2002
7	Edema (Dropsy) 03/2024 - 08/2019
7	Melanoma (Melanoma, Malignant) 12/2023 - 05/2009
7	Corneal Diseases (Corneal Disease) 02/2023 - 10/2009
7	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 12/2007
7	Dry Eye Syndromes (Dry Eye Syndrome) 05/2021 - 12/2012
7	Macular Edema 07/2020 - 03/2016
6	Corneal Injuries 01/2024 - 03/2013
6	Keratitis 11/2017 - 07/2002
5	Retinal Detachment (Retinal Detachments) 04/2024 - 09/2017
5	Uveitis 05/2023 - 04/2014
5	Corneal Edema 01/2023 - 01/2017
5	Infections 06/2021 - 12/2007
5	Hereditary Corneal Dystrophies 06/2018 - 12/2007
4	Blindness (Hysterical Blindness) 03/2024 - 10/2005
4	Limbal Stem Cell Deficiency 01/2024 - 02/2008
4	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 04/2014
4	Hypersensitivity (Allergy) 05/2017 - 08/2004
3	Corneal Opacity 01/2024 - 01/2015
3	Pain (Aches) 01/2023 - 10/2019
3	COVID-19 01/2022 - 07/2020
3	Eye Diseases (Eye Disease) 01/2022 - 05/2015
2	Cicatrix (Scar) 06/2023 - 01/2018
2	Proliferative Vitreoretinopathy 05/2023 - 09/2017
2	Pterygium 02/2023 - 01/2021
2	Postoperative Pain 01/2023 - 10/2019
2	Astigmatism 09/2022 - 01/2014
2	Blister (Bulla) 12/2020 - 01/2019
2	Ocular Hypertension (Glaucoma, Suspect) 02/2019 - 12/2016
2	Chemical Burns (Chemical Burn) 01/2019 - 02/2008
2	Retinal Diseases 05/2018 - 04/2014
2	Atopic Dermatitis (Atopic Eczema) 05/2017 - 04/2009
2	Disease Progression 01/2017 - 12/2014
2	Nevus (Nevi) 04/2014 - 05/2002
1	Myofibromatosis 05/2024

Drug/Important Bio-Agent (IBA)

15	Ophthalmic Solutions (Eye Drops)IBA 06/2023 - 12/2007
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 05/2009
9	Bevacizumab (Avastin)FDA Link 01/2022 - 06/2007
7	Retinaldehyde (Retinal)IBA 04/2024 - 04/2014
7	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2005
5	SteroidsIBA 06/2023 - 03/2016
5	CollagenIBA 01/2022 - 01/2011
5	GS 101IBA 09/2014 - 09/2009
4	AntigensIBA 01/2023 - 08/2004
4	Biomarkers (Surrogate Marker)IBA 03/2021 - 05/2014
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2017 - 10/2005
4	CytokinesIBA 09/2017 - 01/2014
3	Hyaluronan ReceptorsIBA 12/2020 - 07/2002
3	2,4- diamino- 5- cyclohexyl- 6- methylpyrimidineIBA 05/2018 - 12/2016
3	Vascular Endothelial Growth Factor CIBA 01/2016 - 04/2004
3	Thrombospondin 1IBA 09/2015 - 04/2004
3	Antisense OligonucleotidesIBA 09/2014 - 09/2009
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 03/2024 - 10/2022
2	Sulfur HexafluorideIBA 01/2022 - 01/2019
2	Complement System Proteins (Complement)IBA 05/2021 - 03/2021
2	Dexamethasone (Maxidex)FDA LinkGeneric 05/2019 - 04/2014
2	Clostridium sordellii lethal toxin LTIBA 02/2019 - 12/2016
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2019 - 09/2015
2	Riboflavin (Vitamin B2)FDA LinkGeneric 12/2018 - 03/2009
2	Transforming Growth Factor beta (TGF-beta)IBA 09/2017 - 02/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2017 - 08/2002
2	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2017 - 08/2004
2	N-formyl-13-dihydrocarminomycin (NFD)IBA 09/2015 - 12/2014
2	Insulin Receptor Substrate ProteinsIBA 09/2014 - 09/2009
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2014 - 03/2012
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2014 - 07/2006
2	Ranibizumab (Lucentis)FDA Link 03/2014 - 03/2012
2	OptisolIBA 09/2013 - 07/2012
2	Melanins (Melanin)IBA 05/2009 - 05/2002
1	Imatinib Mesylate (Gleevec)FDA Link 05/2024
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 05/2024
1	Trypan Blue FDA Link 01/2024

Therapy/Procedure

68	Corneal Transplantation (Keratoplasty) 04/2024 - 10/2002
23	Sutures (Suture) 06/2023 - 04/2004
21	Therapeutics 12/2023 - 08/2002
9	Trabeculectomy (Trabeculoplasty) 03/2024 - 09/2013
9	Penetrating Keratoplasty 09/2022 - 02/2006
7	Lasers (Laser) 05/2023 - 04/2007
5	Phacoemulsification 04/2024 - 07/2012
5	Transplantation 01/2024 - 09/2009
5	Slit Lamp 02/2021 - 04/2014
3	Excimer Lasers 01/2024 - 10/2002
3	Diathermy 01/2022 - 08/2012
2	Keratectomy 01/2024 - 03/2018
2	Conservative Treatment 06/2023 - 06/2008
2	Contact Lenses 06/2023 - 12/2022
2	Refractive Surgical Procedures 12/2022 - 01/2019
2	Ambulatory Surgical Procedures (Outpatient Surgery) 10/2019 - 02/2011
2	Trephining 06/2012 - 10/2002
2	Organ Transplantation 01/2011 - 07/2010
2	Off-Label Use 10/2009 - 01/2008
2	Drug Therapy (Chemotherapy) 06/2008 - 01/2003